Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / GSK - Aurinia Pharmaceuticals: A Great Candidate For A Potential Buyout In 2021

GSK - Aurinia Pharmaceuticals: A Great Candidate For A Potential Buyout In 2021

GlaxoSmithKline PLC
  • On January 22, the FDA approved Voclosporin to treat Lupus Nephritis.
  • A label was included with a personal dosage protocol, which implies that VC will be protected against generics until 2037.
  • VC is expected to generate between $1B and $2B per year.
  • Aurinia is going to be a prime target for some great Pharma in the coming months.

For further details see:

Aurinia Pharmaceuticals: A Great Candidate For A Potential Buyout In 2021
Stock Information
Company Name: GlaxoSmithKline PLC
Stock Symbol: GSK
Market: NYSE
Website: gsk.com
Menu
GSK GSK Quote GSK Short GSK News GSK Articles GSK Message Board
Get GSK Alerts

News, Short Squeeze, Breakout and More Instantly...